Literature DB >> 27781199

Feasibility of Extracted-Overlay Fusion Imaging for Intraoperative Treatment Evaluation of Radiofrequency Ablation for Hepatocellular Carcinoma.

Yuki Makino1, Yasuharu Imai1, Takumi Igura1, Sachiyo Kogita1, Yoshiyuki Sawai1, Kazuto Fukuda1, Takayuki Iwamoto1, Junya Okabe1, Manabu Takamura2, Norihiko Fujita2, Masatoshi Hori3, Tetsuo Takehara4, Masatoshi Kudo5, Takamichi Murakami6.   

Abstract

BACKGROUND AND AIMS: Extracted-overlay fusion imaging is a novel computed tomography/magnetic resonance-ultrasonography (CT/MR-US) imaging technique in which a target tumor with a virtual ablative margin is extracted from CT/MR volume data and synchronously overlaid on US images. We investigated the applicability of the technique to intraoperative evaluation of radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC).
METHODS: This retrospective study analyzed 85 HCCs treated with RFA using extracted-overlay fusion imaging for guidance and evaluation. To perform RFA, an electrode was inserted targeting the tumor and a virtual 5-mm ablative margin overlaid on the US image. Following ablation, contrast-enhanced US (CEUS) was performed to assess the ablative margin, and the minimal ablative margins were categorized into three groups: (I) margin <0 mm (protrusion), (II) margin 0 to <5 mm, and (III) margin ≥5 mm. Margin assessment was based on the positional relationship between the overlaid tumor plus margin and the perfusion defect of the ablation zone. Tumors in group I underwent repeat ablation until they were in groups II or III. The final classifications were compared with those obtained by retrospectively created fusion images of pre- and post-RFA CT or MR imaging (CT-CT/MR-MR fusion imaging).
RESULTS: Treatment evaluation was impossible using CEUS in six HCCs because the tumors were located far below the body surface. Of the remaining 79 HCCs, the categorizations of minimal ablative margins between CEUS extracted-overlay fusion imaging and CT-CT/MR-MR fusion imaging were in agreement for 72 tumors (91.1%) (Cohen's quadratic-weighted kappa coefficient 0.66, good agreement, p<0.01).
CONCLUSIONS: Extracted-overlay fusion imaging combined with CEUS is feasible for the evaluation of RFA and enables intraoperative treatment evaluation without the need to perform contrast-enhanced CT.

Entities:  

Keywords:  Contrast-enhanced ultrasonography; Extracted-overlay fusion imaging; Hepatocellular carcinoma; Multimodality fusion imaging; Radiofrequency ablation

Year:  2016        PMID: 27781199      PMCID: PMC5075812          DOI: 10.1159/000449338

Source DB:  PubMed          Journal:  Liver Cancer        ISSN: 1664-5553            Impact factor:   11.740


  26 in total

1.  Safety margin assessment after radiofrequency ablation of the liver using registration of preprocedure and postprocedure CT images.

Authors:  Kyung Won Kim; Jeong Min Lee; Ernst Klotz; Soo Jin Kim; Se Hyung Kim; Ji Young Kim; Joon Koo Han; Byung Ihn Choi
Journal:  AJR Am J Roentgenol       Date:  2011-05       Impact factor: 3.959

Review 2.  Usefulness of the multimodality fusion imaging for the diagnosis and treatment of hepatocellular carcinoma.

Authors:  Yuki Makino; Yasuharu Imai; Takumi Igura; Hideko Ohama; Sachiyo Kogita; Yoshiyuki Sawai; Kazuto Fukuda; Hiroshi Ohashi; Takamichi Murakami
Journal:  Dig Dis       Date:  2012-12-13       Impact factor: 2.404

3.  Contrast-enhanced ultrasound (CEUS) follow-up after radiofrequency ablation or cryoablation of focal liver lesions: treated-area patterns and their changes over time.

Authors:  Aymeric Guibal; Caroline Bertin; Sophie Egels; Eric Savier; Philippe A Grenier; Olivier Lucidarme
Journal:  Eur Radiol       Date:  2012-11-09       Impact factor: 5.315

4.  Three-dimensional registration of images obtained before and after radiofrequency ablation of hepatocellular carcinoma to assess treatment adequacy.

Authors:  Mitsuru Sakakibara; Kazuyoshi Ohkawa; Kazuhiro Katayama; Kazuho Imanaka; Akio Ishihara; Noriko Hasegawa; Haruki Kimura
Journal:  AJR Am J Roentgenol       Date:  2014-05       Impact factor: 3.959

5.  Radiofrequency ablation of hepatocellular carcinoma: correlation between local tumor progression after ablation and ablative margin.

Authors:  Takahide Nakazawa; Shigehiro Kokubu; Akitaka Shibuya; Koji Ono; Masaaki Watanabe; Hisashi Hidaka; Takeshi Tsuchihashi; Katsunori Saigenji
Journal:  AJR Am J Roentgenol       Date:  2007-02       Impact factor: 3.959

6.  Use of fusion imaging combining contrast-enhanced ultrasonography with a perflubutane-based contrast agent and contrast-enhanced computed tomography for the evaluation of percutaneous radiofrequency ablation of hypervascular hepatocellular carcinoma.

Authors:  Kazushi Numata; Hiroyuki Fukuda; Manabu Morimoto; Masaaki Kondo; Akito Nozaki; Takashi Oshima; Masahiro Okada; Shigeo Takebayashi; Shin Maeda; Katsuaki Tanaka
Journal:  Eur J Radiol       Date:  2011-12-23       Impact factor: 3.528

Review 7.  Navigation systems for ablation.

Authors:  Bradford J Wood; Jochen Kruecker; Nadine Abi-Jaoudeh; Julia K Locklin; Elliot Levy; Sheng Xu; Luigi Solbiati; Ankur Kapoor; Hayet Amalou; Aradhana M Venkatesan
Journal:  J Vasc Interv Radiol       Date:  2010-08       Impact factor: 3.464

8.  Usefulness of the extracted-overlay function in CT/MR-ultrasonography fusion imaging for radiofrequency ablation of hepatocellular carcinoma.

Authors:  Yuki Makino; Yasuharu Imai; Takumi Igura; Sachiyo Kogita; Yoshiyuki Sawai; Kazuto Fukuda; Masatoshi Hori; Masatoshi Kudo; Takamichi Murakami
Journal:  Dig Dis       Date:  2013-11-21       Impact factor: 2.404

9.  Radiofrequency ablation of hepatocellular carcinoma: The feasibility of magnetic resonance imaging with gadolinium ethoxybenzyl diethylene triamine pentaacetic acid for evaluating the ablative margin.

Authors:  Hironao Okubo; Shigehiro Kokubu; Masae Komiyama; Hisafumi Yamagata; Akira Uchiyama; Akihisa Miyazaki; Sumio Watanabe
Journal:  Hepatol Res       Date:  2010-10       Impact factor: 4.288

10.  Radiofrequency ablation of the liver: determination of ablative margin at MR imaging with impaired clearance of ferucarbotran--feasibility study.

Authors:  Kensaku Mori; Kuniaki Fukuda; Hitoshi Asaoka; Takuya Ueda; Akira Kunimatsu; Yoshikazu Okamoto; Katsuhiro Nasu; Kiyoshi Fukunaga; Yukio Morishita; Manabu Minami
Journal:  Radiology       Date:  2009-02-27       Impact factor: 11.105

View more
  10 in total

1.  Fusion imaging with contrast-enhanced ultrasonography for evaluating the early therapeutic efficacy of radiofrequency ablation for small hypervascular hepatocellular carcinomas with iso-echoic or unclear margins on conventional ultrasonography.

Authors:  Shuhei Nishigori; Kazushi Numata; Kuniyasu Irie; Hiroyuki Fukuda; Makoto Chuma; Shin Maeda
Journal:  J Med Ultrason (2001)       Date:  2018-01-23       Impact factor: 1.314

2.  Ultrasound-ultrasound image overlay fusion improves real-time control of radiofrequency ablation margin in the treatment of hepatocellular carcinoma.

Authors:  Yasunori Minami; Tomohiro Minami; Satoru Hagiwara; Hiroshi Ida; Kazuomi Ueshima; Naoshi Nishida; Takamichi Murakami; Masatoshi Kudo
Journal:  Eur Radiol       Date:  2017-12-01       Impact factor: 5.315

3.  A Hybrid Machine Learning Model Based on Semantic Information Can Optimize Treatment Decision for Naïve Single 3-5-cm HCC Patients.

Authors:  Wenzhen Ding; Zhen Wang; Fang-Yi Liu; Zhi-Gang Cheng; Xiaoling Yu; Zhiyu Han; Hui Zhong; Jie Yu; Ping Liang
Journal:  Liver Cancer       Date:  2022-01-28       Impact factor: 12.430

4.  Preoperative Visceral Adiposity and Muscularity Predict Poor Outcomes after Hepatectomy for Hepatocellular Carcinoma.

Authors:  Yuhei Hamaguchi; Toshimi Kaido; Shinya Okumura; Atsushi Kobayashi; Hisaya Shirai; Siyuan Yao; Shintaro Yagi; Naoko Kamo; Satoru Seo; Kojiro Taura; Hideaki Okajima; Shinji Uemoto
Journal:  Liver Cancer       Date:  2018-06-05       Impact factor: 11.740

Review 5.  [Contrast-enhanced ultrasound (CEUS) and image fusion for procedures of liver interventions].

Authors:  E M Jung; D A Clevert
Journal:  Radiologe       Date:  2018-06       Impact factor: 0.635

6.  F-18 FDG perfusion PET: intraprocedural assessment of the liver tumor ablation margin.

Authors:  Paul B Shyn; Alan J Cubre; Paul J Catalano; Leslie K Lee; Hyewon Hyun; Kemal Tuncali; Julia G Seol; Vincent M Levesque; Victor H Gerbaudo; Tina Kapur; Ryan T Chao; Stuart G Silverman
Journal:  Abdom Radiol (NY)       Date:  2021-02-19

7.  A tumor map generated from three-dimensional visualization of image fusion for the assessment of microwave ablation of hepatocellular carcinoma: a preliminary study.

Authors:  Chao An; Xin Li; Ping Liang; Jie Yu; Zhigang Cheng; Zhiyu Han; Fangyi Liu; Linan Dong
Journal:  Cancer Manag Res       Date:  2019-02-15       Impact factor: 3.989

8.  Quantitative margin assessment of radiofrequency ablation of a solitary colorectal hepatic metastasis using MIRADA RTx on CT scans: a feasibility study.

Authors:  B G Sibinga Mulder; P Hendriks; T R Baetens; A R van Erkel; C S P van Rijswijk; R W van der Meer; C J H van de Velde; A L Vahrmeijer; J S D Mieog; M C Burgmans
Journal:  BMC Med Imaging       Date:  2019-08-20       Impact factor: 1.930

9.  Improving Ablation Safety for Hepatocellular Carcinoma Proximal to the Hilar Bile Ducts by Ultrasound-MR Fusion Imaging: A Preliminary Comparative Study.

Authors:  Yujia You; Yinglin Long; Ronghua Yan; Liping Luo; Man Zhang; Lu Li; Qingjing Zeng; Kai Li; Rongqin Zheng; Erjiao Xu
Journal:  Front Oncol       Date:  2021-03-01       Impact factor: 6.244

10.  An Optimal Ablative Margin of Small Single Hepatocellular Carcinoma Treated with Image-Guided Percutaneous Thermal Ablation and Local Recurrence Prediction Base on the Ablative Margin: A Multicenter Study.

Authors:  Feng-Yao Li; Jian-Guo Li; Song-Song Wu; Huo-Lin Ye; Xu-Qi He; Qing-Jing Zeng; Rong-Qin Zheng; Chao An; Kai Li
Journal:  J Hepatocell Carcinoma       Date:  2021-11-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.